Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Alcami Carolinas Corporation
EIR
•Alcami Carolinas Corporation•February 21, 2019

Alcami Carolinas Corporation – FDA EIR, Feb 21, 2019

Record Details

An FDA Pre-Approval Inspection (PAI) was conducted at Alcami Carolinas Corporation in Charleston, SC, from February 18-21, 2019. This inspection, initiated by the Center for Drug Evaluation and Research, focused on assessing the facility's readiness for commercial manufacturing of a new sterile injectable product and its conformance to the filed application. It was explicitly a PAI, not a routine Current Good Manufacturing Practices (cGMP) inspection.

While no formal Form FDA 483, Inspectional Observations, was issued, inspectors verbally communicated five key observations to management. These included an insufficient investigation into a deviation concerning sample shipping, a lack of documented assurance that cleanroom personnel had corrected previously noted rapid movement, and inadequate time documentation for handling the active pharmaceutical ingredient (API), along with concerns regarding rusted and dented secondary API containers. Other issues involved untimely Good Documentation Practice (GDP) markings in batch records, made months after manufacturing, and significant overcrowding in storage areas, including fridges, freezers, hold, and quarantine.

The FDA team recommended approval for the application product but reminded Alcami of its responsibility to adhere to cGMP. The verbal observations highlight areas where Alcami is expected to implement improvements to ensure compliant and controlled manufacturing operations.

Company
Alcami Carolinas Corporation
Inspection date
February 21, 2019
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Rachael L. Cook (Investigator)
  • Adam R. Cooke (Commissioned Corps of the U.S. Public Health Service)
View Company Profile

ID · be6f5633-cc0c-4ad3-bfe8-c3d20373accf

Violation Codes1
21 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Alcami Carolinas Corporation
  • 483 - 2026-04-22April 22, 2026
  • 483 - 2026-02-06February 6, 2026
  • 483 - 2024-04-05April 5, 2024
  • 483 - 2021-10-29October 29, 2021
  • 483 - 2018-03-15March 15, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alcami Carolinas Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.